Bayer AG (OTCMKTS:BAYRY) Receives Average Recommendation of “Buy” from Analysts
Bayer AG (OTCMKTS:BAYRY) has been given an average recommendation of “Buy” by the fourteen research firms that are currently covering the company. Six analysts have rated the stock with a hold recommendation and eight have assigned a buy recommendation to the company. The average twelve-month target price among brokers that have updated their coverage on the stock in the last year is $130.00.
Several analysts have weighed in on BAYRY shares. Zacks Investment Research downgraded shares of Bayer AG from a “hold” rating to a “sell” rating in a research note on Monday, August 22nd. Goldman Sachs Group Inc. reissued a “buy” rating on shares of Bayer AG in a research note on Wednesday, September 14th. Citigroup Inc. raised shares of Bayer AG from a “neutral” rating to a “buy” rating in a research note on Thursday, August 25th. Sanford C. Bernstein reissued a “buy” rating on shares of Bayer AG in a research note on Thursday, September 15th. Finally, Commerzbank AG raised shares of Bayer AG from a “hold” rating to a “buy” rating in a research note on Wednesday, May 25th.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/21/bayer-ag-otcmktsbayry-receives-average-recommendation-of-buy-from-analysts.html
Bayer AG (OTCMKTS:BAYRY) traded down 0.39% during trading on Wednesday, hitting $102.50. 55,932 shares of the stock were exchanged. The stock has a market cap of $84.76 billion, a P/E ratio of 16.78 and a beta of 1.40. Bayer AG has a 52 week low of $94.36 and a 52 week high of $135.71. The stock has a 50 day moving average of $107.05 and a 200-day moving average of $107.71.
Bayer AG Company Profile
Bayer AG is a Germany-based chemical and pharmaceutical company. The Company’s business operations are organized into three segments: Bayer HealthCare, Bayer CropScience and Bayer MaterialScience, supported by the service companies Bayer Business Services, Bayer Technology Services and Currenta. Bayer HealthCare researches, develops, manufactures and markets products to improve the health of people and animals.
Receive News & Ratings for Bayer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer AG and related companies with MarketBeat.com's FREE daily email newsletter.